Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: TAKEDA PHARMACEUTICALS AMERICA, INC.
FY 2010 U.S. Treasury Green Book on Administration; H.Con.Res 85/S.Con.Res. 13 Concurrent Resolution on the Budget for FY2010; HR 2997 FY 2010 Agriculture Appropriations; FY 2010 Homeland Security Department; FY 2010 Commerce State Justice Appropriations
Pathway for Biosimilars Act
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: TAKEDA PHARMACEUTICALS AMERICA, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
TAKEDA PHARMACEUTICALS AMERICA INC via TAKEDA PHARMACEUTICALS AMERICA, INC.
2009 · third_quarter · Q3
HR. 444 340B Program Improvement and Integrity Act of 2009, HR 684/S 330 The Medicare Prescription Drug Savings and Choice Act of 2009, HR 904 Medicaid Prescription Drug Rebate Equalization Act of 2009, Part D general issues, Protected Classes, Comparative Effectiveness, general Medicare/Medicaid expansions and reform, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance Committee Roundtable health reform options
FY 2010 U.S. Treasury Green Book on Administration; H.Con.Res 85/S.Con.Res. 13 Concurrent Resolution on the Budget for FY2010; HR 2997 FY 2010 Agriculture Appropriations; FY 2010 Homeland Security Department; FY 2010 Commerce State Justice Appropriations
Source: Senate LDA
S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, H.R. 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance health reformoptions H.R. 1995 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2009, FTC Report "Emerging Health Care Issues: Follow-on Bilogic Drug Competition," mental health parity, value based insurance design, quality of care, adhereance.
Diabetes in Minority Populations Evaluation Act of 2010
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: TAKEDA PHARMACEUTICALS AMERICA, INC.
S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, H.R. 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance health reformoptions H.R. 1995 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2009, FTC Report "Emerging Health Care Issues: Follow-on Bilogic Drug Competition," mental health parity, value based insurance design, quality of care, adhereance.
America's Affordable Health Choices Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: TAKEDA PHARMACEUTICALS AMERICA, INC.
HR. 444 340B Program Improvement and Integrity Act of 2009, HR 684/S 330 The Medicare Prescription Drug Savings and Choice Act of 2009, HR 904 Medicaid Prescription Drug Rebate Equalization Act of 2009, Part D general issues, Protected Classes, Comparative Effectiveness, general Medicare/Medicaid expansions and reform, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance Committee Roundtable health reform options
America's Affordable Health Choices Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: TAKEDA PHARMACEUTICALS AMERICA, INC.
S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, H.R. 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance health reformoptions H.R. 1995 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2009, FTC Report "Emerging Health Care Issues: Follow-on Bilogic Drug Competition," mental health parity, value based insurance design, quality of care, adhereance.
Notify Americans Before Outsourcing Personal Information Act
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: TAKEDA PHARMACEUTICALS AMERICA, INC.
S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, H.R. 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance health reformoptions H.R. 1995 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2009, FTC Report "Emerging Health Care Issues: Follow-on Bilogic Drug Competition," mental health parity, value based insurance design, quality of care, adhereance.
340B Program Improvement and Integrity Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: TAKEDA PHARMACEUTICALS AMERICA, INC.
HR. 444 340B Program Improvement and Integrity Act of 2009, HR 684/S 330 The Medicare Prescription Drug Savings and Choice Act of 2009, HR 904 Medicaid Prescription Drug Rebate Equalization Act of 2009, Part D general issues, Protected Classes, Comparative Effectiveness, general Medicare/Medicaid expansions and reform, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance Committee Roundtable health reform options
Medicare Prescription Drug Savings and Choice Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: TAKEDA PHARMACEUTICALS AMERICA, INC.
HR. 444 340B Program Improvement and Integrity Act of 2009, HR 684/S 330 The Medicare Prescription Drug Savings and Choice Act of 2009, HR 904 Medicaid Prescription Drug Rebate Equalization Act of 2009, Part D general issues, Protected Classes, Comparative Effectiveness, general Medicare/Medicaid expansions and reform, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance Committee Roundtable health reform options
Medicaid Prescription Drug Rebate Equalization Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: TAKEDA PHARMACEUTICALS AMERICA, INC.
HR. 444 340B Program Improvement and Integrity Act of 2009, HR 684/S 330 The Medicare Prescription Drug Savings and Choice Act of 2009, HR 904 Medicaid Prescription Drug Rebate Equalization Act of 2009, Part D general issues, Protected Classes, Comparative Effectiveness, general Medicare/Medicaid expansions and reform, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance Committee Roundtable health reform options
Physician Payments Sunshine Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: TAKEDA PHARMACEUTICALS AMERICA, INC.
S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, H.R. 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance health reformoptions H.R. 1995 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2009, FTC Report "Emerging Health Care Issues: Follow-on Bilogic Drug Competition," mental health parity, value based insurance design, quality of care, adhereance.
Medicare Prescription Drug Savings and Choice Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: TAKEDA PHARMACEUTICALS AMERICA, INC.
HR. 444 340B Program Improvement and Integrity Act of 2009, HR 684/S 330 The Medicare Prescription Drug Savings and Choice Act of 2009, HR 904 Medicaid Prescription Drug Rebate Equalization Act of 2009, Part D general issues, Protected Classes, Comparative Effectiveness, general Medicare/Medicaid expansions and reform, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance Committee Roundtable health reform options
Sunshine in Litigation Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: TAKEDA PHARMACEUTICALS AMERICA, INC.
S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, H.R. 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance health reformoptions H.R. 1995 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2009, FTC Report "Emerging Health Care Issues: Follow-on Bilogic Drug Competition," mental health parity, value based insurance design, quality of care, adhereance.
Pre-existing Condition Patient Protection Act of 2009
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: TAKEDA PHARMACEUTICALS AMERICA, INC.
S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, H.R. 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance health reformoptions H.R. 1995 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2009, FTC Report "Emerging Health Care Issues: Follow-on Bilogic Drug Competition," mental health parity, value based insurance design, quality of care, adhereance.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: TAKEDA PHARMACEUTICALS AMERICA, INC.
S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, H.R. 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance health reformoptions H.R. 1995 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2009, FTC Report "Emerging Health Care Issues: Follow-on Bilogic Drug Competition," mental health parity, value based insurance design, quality of care, adhereance.
S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, H.R. 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance health reformoptions H.R. 1995 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2009, FTC Report "Emerging Health Care Issues: Follow-on Bilogic Drug Competition," mental health parity, value based insurance design, quality of care, adhereance.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
TAKEDA PHARMACEUTICALS AMERICA INC via TAKEDA PHARMACEUTICALS AMERICA, INC.
2008 · first_quarter · RA
General pharmacutical issues
General pharmacutical issues
General pharmacutical issues
General pharmacutical issues
General pharmacutical issues
General pharmacutical issues
TAKEDA PHARMACEUTICALS AMERICA INC via TAKEDA PHARMACEUTICALS AMERICA, INC.
2008 · first_quarter · RA
General pharmaceutical issues
General pharmaceutical issues
General pharmaceutical issues
General pharmaceutical issues
General pharmaceutical issues
General pharmaceutical issues